Sarah E Kolnik

Dr. Sarah E Kolnik

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SKSarah E Kolnik
Sarah E Kolnik
KUKirtikumar Upadhyay
Kirtikumar Upadhyay
TWThomas R. Wood
Thomas R. Wood
SJSandra E. Juul
Sandra E. Juul
GVGregory C. Valentine
Gregory C. Valentine
Intraventricular hemorrhage prevention bundles (IVHPBs) can decrease the incidence of intraventricular hemorrhage (IVH) in premature infants. Our center had a high rate of severe (grade III/IV) IVH (9.8%), and poor adherence (24%) to an IVHPB in neonates born ≤1250 g or ≤30 gestational weeks. Improvement initiatives were planned to decrease the incidence of severe IVH by 30% over 2 years. A multidisciplinary team undertook interventions including in-service training, prompt initiation of IVHPB, revision of guidelines, and process standardization. Baseline data were collected from May 2016 to June 2018, with interventions occurring from July 2018 to May 2020. Adherence to the IVHPB was the primary process measure, and incidence of severe IVH the primary outcome measure. Control charts were used to analyze the effect of interventions on outcome. Balancing measures included use of breast milk at discharge, use of mechanical ventilation after initial resuscitation, and bronchopulmonary dysplasia. A total of 240 infants were assessed preintervention, and 185 during interventions. Adherence to the IVHPB improved from 24% to 88%. During this period, the incidence of severe IVH decreased from 9.8% to 2.4%, a 76% reduction from baseline. A higher adherence score was associated with reduced odds of IVH (odds ratio 0.30; 95% confidence interval 0.10–0.90, P = .03). Interventions focused on enhancing adherence to an IVHPB were associated with a reduced rate of severe IVH in high-risk neonates, highlighting the importance of assessing adherence to clinical guidelines.

20 July 2022 in Life
Verified
Journal Article
Open access
PDF file
SKSarah E Kolnik
Sarah E Kolnik
TWTommy Wood
Tommy Wood
Vitamin E (Vit E) is an essential lipophilic antioxidant and anti-inflammatory agent that has potential as a neuroprotectant in newborn infants with brain injury. Vit E has shown promise in many in vitro studies, but success in translation to in vivo animal studies and the clinical setting has been mixed, with concern of adverse effects at high intravenous doses in preterm infants. However, a recent rise in knowledge of the beneficial effects of fat emulsions containing higher levels of Vit E, along with associated improved outcomes in some neonatal co-morbidities, has led many to reconsider Vit E administration as a potential therapeutic modality to improve neurological outcomes in the setting of neonatal brain injury. This narrative review discusses Vit E’s structure, mechanism(s) of action, evidence in animal models, and association with health outcomes in neonates, including both dietary and supplemental Vit E and their bioavailability and pharmacokinetics as it relates to the brain. Lastly, long-term neurodevelopmental outcomes along with gaps in current knowledge are critiqued, which to date suggests that additional translational studies in larger animal models and assessment of safety profiles of different routes and doses of administration should be explored prior to large clinical trials. Importantly, a greater understanding of the brain region(s) and cell type(s) affected by Vit E may help to target the use of Vit E as a beneficial neuroprotective agent to specific populations or types of injury seen in newborns.

9 January 2024 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
KSKatie M Strobel
Katie M Strobel
TWTommy Wood
Tommy Wood
GVGregory Valentine
Gregory Valentine
KGKendell R. German
Kendell R. German
SGSemsa Gogcu
Semsa Gogcu
SJSandra E Juul
Sandra E Juul
Background: Associations of 2-year neurodevelopmental and behavioral outcomes with growth trajectories of preterm infants are unknown. Methods: This secondary analysis of a preterm cohort examined in-hospital and discharge to 2-year changes in anthropometric z-scores. Two-year follow-up included Bayley Scales of Infant Development (BSID-III) and Child Behavior Checklist. Results: Among 590 infants, adjusted in-hospital growth was not associated with any BSID-III subscale. Occipitofrontal circumference (OFC) growth failure (GF) in-hospital was associated with increased adjusted odds of attention problems (aOR 1.65 [1.03, 2.65]), aggressive behavior (aOR 2.34 [1.12, 4.89]), and attention-deficit-hyperactivity symptoms (aOR 1.86 [1.05, 3.30]). Infants with OFC GF at 2 years had lower adjusted BSID-III language scores (−4.0 [−8.0, −0.1]), increased odds of attention problems (aOR 2.29 [1.11, 4.74]), aggressive behavior (aOR 3.09 [1.00, 9.56]), and externalizing problems (aOR 3.01 [1.07, 8.45]) compared to normal OFC growth cohort. Conclusion: Infants with OFC GF are at risk for neurodevelopmental and behavioral impairment. Clinical trial registration: This study is a secondary analysis of pre-existing data from the PENUT Trial Registration: NCT01378273.

29 October 2022 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
BABenjamin J.S. al-Haddad
Benjamin J.S. al-Haddad
BBBrittany Bergam
Brittany Bergam
AJAlicia Johnson
Alicia Johnson
SKSarah E Kolnik
Sarah E Kolnik
TTTaylor Thompson
Taylor Thompson
KGKendell German
Kendell German

9 January 2024 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
GVGregory Valentine
Gregory Valentine
KPKrystle M. Perez
Krystle M. Perez
TWTommy Wood
Tommy Wood
DMDennis Edward Mayock
Dennis Edward Mayock
JLJanessa B. Law
Janessa B. Law
SJSandra E Juul
Sandra E Juul

25 February 2024 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
SKSarah E Kolnik
Sarah E Kolnik
ASAnnika Sahota
Annika Sahota
TWThomas R. Wood
Thomas R. Wood
KGKendell German
Kendell German
MPMihai Puia-Dumitrescu
Mihai Puia-Dumitrescu
JLJanessa B. Law
Janessa B. Law